Skip to main content

Table 4 Discharge outcomes for those survived during the index admission

From: In-hospital and post-discharge outcomes of pediatric acute myocarditis underwent after high-dose steroid or intravenous immunoglobulin therapy

 

First cohort

Second cohort

Variable

Non-Steroid*

Steroid*

P‡

Non-IVIG

IVIG

P‡

Number of patients

181

91

–

168

84

–

VT/VF—no. (%)

2 (1.1)

0 (0.0)

–

0 (0.0)

0 (0.0)

–

High-grade AVB—no. (%)

1 (0.6)

0 (0.0)

–

0 (0.0)

0 (0.0)

–

Cardiac arrest—no. (%)

0 (0.0)

1 (1.1)

–

0 (0.0)

0 (0.0)

–

Heart failure—no. (%)

14 (7.7)

8 (8.8)

0.891

6 (3.6)

2 (2.4)

0.581

Heart transplantation—no. (%)

0 (0.0)

0 (0.0)

–

0 (0.0)

0 (0.0)

–

Any dialysis—no. (%)

0 (0.0)

0 (0.0)

–

0 (0.0)

0 (0.0)

–

New occurrence of dialysis

0 (0.0)

0 (0.0)

–

0 (0.0)

0 (0.0)

–

All-cause mortality

16 (8.8)

9 (9.9)

0.919

8 (4.8)

0 (0.0)

–

CV death

8 (4.4)

4 (4.4)

0.871

4 (2.4)

0 (0.0)

–

  1. ‡ Adjusted for propensity score (Cox regression);
  2. *Steroid: those patients received high-dose steroid therapy; non-steroid: those patients without receiving high-dose steroid therapy
  3. Abbreviations: AVB atrioventricular block, CV cardiovascular, IVIG intravenous immunoglobulin, VT ventricular tachycardia, VF ventricular fibrillation